Comunicación
Nº 041
Comunicación |
|
Giorgio Gherardi, M.D., Cristina Marveggio, B.D., Stefania Rossi, M.D.
|
|
1.- Thomas PA, Raab SS: Fine needle aspiration biopsy cytology of atypical ductal hyperplasia. Pathology Case Reviews 1996 ;1 :12-16.
2.- Al-Kaisi N. : The spectrum of the "grey zone" in breast cytology. A review of 186 cases of atypical and suspicious cytology. Acta Cytol 1994 ;38:898-908.
3.- Kreuzer G, Zaijcek J: Cytologic diagnosis of mammary tumors from aspiration biopsy smears: III. Studies on 200 carcinomas with false negative or doubtful cytologic reports. Acta Cytol 1972 ;16:249-252.
4.- Patel J, Cartell PC, Smallwood JA, Herbert A, Royle GT, Buchanan R, Taylor I: Fine-needle aspiration cytology of breast masses: an evaluation of its accuracy and reasons for diagnostic failure. Ann R Coll Surg 1987 ;69:156-159.
5.- Scopa CD, Koukuras D, Androulakis J, Bonikos D: Sources of diagnostic discrepancies in fine-needle aspiration of the breast. Diagn Cytopathol 1991 ;7:731-736.
6.- Masood S, Frykberg ER, McLellan GL, Dee S, Bullard JB: Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine-needle aspirates. Diagn Cytopathol 1991 ;7:581-590.
7.- Masood S, Frykberg ER, McLellan GL, Scalapino MC, Mitchum DG, Bullard LB: Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalpable breast lesions. Cancer 1990; 66:1480-1487.
8.- Masood S, Hardy NM, Assaf N, Lu L: Cytologic grading system in diagnosis of high risk and malignant breast lesions: merits and pitfalls. Acta Cytol 1994;38:797-798.
9.- Sneige N, Staerkel GA. Fine needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ. Hum Pathol 1994;25:485-492
10.- Dawson AE, Mulford DK, Sheils LA. The cytopathology of proliferative breast disease: comparison with features of ductal carcinoma in situ. Am J Clin Pathol 1995;103:438-442.
11.- Schmitt FC, Figueiredo P, Lacerda M. Expression of c-erb B-2 and DNA ploidy in breast carcinogenesis. Arch Pathol Lab Med 1995;119:815-820
12.- Carpenter R, Gibbs N, Matthews J, Cooke T. Importance of cellular DNA content in pre-malignant breast disease and preinvasive carcinoma of the female breast. Br J Surg 1987;74:905-906
13.- Teplitz RL, Butler BB, Tesluk H, Min BH, Russell LA, Jensen HM, Hill LR. Quantitative DNA patterns in human preneoplastic breast lesions. Anal Quant Cytol Histol 1990;12:98-102
14.- Visscher DW, Sarkar FH, Crissman JD. Correlation of DNA ploidy with c-erb B-2 expression in pre-invasive and invasive breast tumors. Anal Quant Cytol Histol 1991;13:418-424
15.- Fisher ER, Sidertis R. Value of cytometric analysis for distinction of intraductal carcinoma of the breast. Breast Cancer Res Treat 1992;21:165-172
16.- Eriksson E, Schimmelpenning H, Silfversward C, Auer G: Immunoreactivity with monoclonal antibody A-80 and nuclear DNA content in benign and malignant human breast disease. Hum Pathol 1992;23:1366-1372
17.- Raju U, Zarbo RJ, Kubus J, Schultz DS. The histologic spectrum of apocrine breast proliferations: a comparative study of morphology and DNA content by image analysis. Hum Pathol 1993;24:173-181
18.- Schmitt FC, Leal C, Lopes C. p53 protein expression and nuclear DNA content in breast intraductal proliferations. J Pathol 1995;176:233-241
19.- Martelli G., Daidone MG, Mastore M, Messina Gabrielli G, Galante E, Pilotti S Silvestrini R: Combined analysis of ploidy and cell kinetics on fine-needle aspirates from breast tumors. Cancer 1993 ;71:2522-7
20.- Abele JS, Miller TR, King EB, et al: Smearing techniques for the concentration of particles from fine needle aspiration biopsy. Diagn Cytopathol 1985 ;1:59-65
21.- Page DL, Rogers LW: Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 1992 ;23,1095-1097
22.- Bacus SS, Press MF, Bakus JW, Slamon DJ: HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer. Arch Pathol Lab Med 1990 ;114:164-169
23.-Taylor SR, Titus-Ernstoff L, Stitely S: Central values of and variation of measured nuclear DNA content in imprints of normal tissues determined by image analysis. Cytom 1989 ;10:382-387
24.- Mayall BH, Mendelsohn ML: Human Chromosome methodology. Edited by JJ Yunis. New York, Academic Press, 1974 : 311-346.
25.- Sidawy MK, Stoler MH, Frable WJ, Frost AR, Masood S, Miller TR, Silverberg SG, Sneige N, Wang HH. Interobserver variability in the classification of proliferative breast lesions by fine-needle aspiration: results of the Papanicolaou Society of Cytopathology Study. Diagn Cytopathol 1998;18:150-165.
26.- De Potter CR, Praet MM, Slavin RE, Verbeeck P, Roels HJ: Feulgen DNA content and mitotic activity in proliferative breast disease. A Comparison with ductal carcinoma in situ. Histopathol 1987 ;11:1307-1319
27.- Visscher DW, Micale MA, Crissman JD. Pathological and biological relevance of cytophotometric DNA content to breast carcinoma genetic progression. J Cell Biochem Suppl 1993;17G:114-122
|
|
